Compugen (CGEN)
(Real Time Quote from BATS)
$1.74 USD
+0.11 (6.75%)
Updated Aug 8, 2024 01:54 PM ET
3-Hold of 5 3
C Value F Growth D Momentum D VGM
Price, Consensus and EPS Surprise
CGEN 1.74 +0.11(6.75%)
Will CGEN be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for CGEN based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CGEN
Compugen (CGEN) Reports Q2 Loss, Tops Revenue Estimates
Alterity (ATHE) Up on Interim Data From Advance MSA Study
CGEN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Lexeo (LXEO) Down Despite Upbeat Rare Disease Gene Therapy Data
Kazia Therapeutics (KZIA) Soars 490% in a Week: Here's Why
Verona (VRNA) Stock Surges 36% in the Past Month: Here's Why
Other News for CGEN
CGEN Stock Earnings: Compugen Beats EPS, Beats Revenue for Q2 2024
Compugen: Q2 Earnings Snapshot
Compugen Reports Second Quarter 2024 Results
Compugen’s Strategic Milestones Boost Q2 2024 Outlook
Compugen reports Q2 EPS (2c), consensus (7c)